ASBP vs AMGN: Which Stock is Better?

Side-by-side comparison of Aspire Biopharma Holdings Inc and Amgen Inc in 2026

Comparison Updated:

ASBP

Aspire Biopharma Holdings Inc

$5.41

AMGN

Amgen Inc

$339.30

Key Metrics Comparison

MetricASBPAMGNWinner
Market Cap$7.01M$183.12BAMGN
P/E RatioN/A23.58AMGN
EPS (TTM)$N/A$14.39AMGN
Revenue Growth0.0%0.1%AMGN
Gross Margin16.3%71.4%AMGN

Analyze ASBP

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ASBP or AMGN a better investment?

Comparing ASBP and AMGN: Aspire Biopharma Holdings Inc has a market cap of $7.01M while Amgen Inc has $183.12B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ASBP and AMGN?

ASBP (Aspire Biopharma Holdings Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ASBP or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ASBP or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.0% for ASBP.

Which company is more profitable: ASBP or AMGN?

Amgen Inc (AMGN) has higher gross margins at 71.4% compared to 16.3% for ASBP.

Which is the larger company: ASBP or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $183.12B compared to $7.01M for ASBP.

Should I buy ASBP or AMGN in 2026?

Both ASBP and AMGN have investment merit. ASBP trades at $5.41 while AMGN trades at $339.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ASBP and AMGN stock?

Key differences: Market Cap ($7.01M vs $183.12B), P/E Ratio (N/A vs 23.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (16.3% vs 71.4%).

Popular Stock Comparisons